| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Alembic Pharmaceuticals Limited (NSE: APLLTD)
APLLTD Technical Analysis
1.5
| As on 24th Apr 2024 APLLTD SHARE Price closed @ 958.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 795.52 & Sell for SHORT-TERM with Stoploss of 989.58 we also expect STOCK to react on Following IMPORTANT LEVELS. |
APLLTDSHARE Price
| Open | 940.40 | Change | Price | % |
| High | 972.15 | 1 Day | 17.75 | 1.89 |
| Low | 940.40 | 1 Week | -7.60 | -0.79 |
| Close | 958.00 | 1 Month | 0.60 | 0.06 |
| Volume | 60861 | 1 Year | 413.85 | 76.05 |
| 52 Week High 793.30 | 52 Week Low 468.65 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.10 | -9.03% |
| SAIL | 164.65 | 8.14% |
| YESBANK | 25.45 | -0.78% |
| TATASTEEL | 165.55 | 2.73% |
| IRFC | 149.00 | 0.85% |
| SOUTHBANK | 29.10 | 1.04% |
| MRPL | 248.70 | 10.75% |
| SUZLON | 41.80 | -0.12% |
| BEL | 236.50 | 0.92% |
| RAMASTEEL | 14.00 | 2.56% |
NSE INDIA Top Gainers Stocks
| ROML | 63.05 | 19.98% |
| COMPUSOFT | 35.20 | 19.93% |
| SHRADHA | 78.55 | 19.83% |
| STEELCITY | 102.95 | 19.78% |
| WEIZMANIND | 142.25 | 19.59% |
| TEMBO | 240.90 | 18.61% |
| CHENNPETRO | 1075.00 | 15.82% |
| YUKEN | 1180.65 | 13.81% |
| ORIENTCEM | 230.50 | 12.85% |
| AEGISCHEM | 604.50 | 12.41% |
NSE INDIA Top Losers Stocks
| APLLTD Daily Charts |
APLLTD Intraday Charts |
Whats New @ Bazaartrend |
APLLTD Free Analysis |
|
|
APLLTD Important Levels Intraday
| RESISTANCE | 1019.18 |
| RESISTANCE | 999.56 |
| RESISTANCE | 987.43 |
| RESISTANCE | 975.30 |
| SUPPORT | 940.70 |
| SUPPORT | 928.57 |
| SUPPORT | 916.44 |
| SUPPORT | 896.82 |
APLLTD Target April 2024
| 4th UP Target | 1448.01 |
| 3rd UP Target | 1321.97 |
| 2nd UP Target | 1244.06 |
| 1st UP Target | 1166.15 |
| 1st DOWN Target | 943.85 |
| 2nd DOWN Target | 865.94 |
| 3rd DOWN Target | 788.03 |
| 4th DOWN Target | 661.99 |
APLLTD Weekly Target
| 4th UP Target | 1113.51 |
| 3rd UP Target | 1057.34 |
| 2nd UP Target | 1022.61 |
| 1st UP Target | 987.89 |
| 1st DOWN Target | 888.81 |
| 2nd DOWN Target | 854.09 |
| 3rd DOWN Target | 819.36 |
| 4th DOWN Target | 763.19 |
APLLTD Target2024
| 4th UP Target | 1485.3 |
| 3rd UP Target | 1252.5 |
| 2nd UP Target | 1108.6 |
| 1st UP Target | 964.7 |
| 1st DOWN Target | 554.1 |
| 2nd DOWN Target | 410.2 |
| 3rd DOWN Target | 266.3 |
| 4th DOWN Target | 33.5 |
Alembic Pharmaceuticals Limited ( NSE INDIA Symbol : APLLTD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
APLLTD Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is 32.82 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 626.49 | |
| 10 Day Avg Volume | Traded 23.47 % More then 10 Day Average Volume | ||
APLLTD Other Details
| Segment | EQ | |
| Market Capital | 149447147520.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
APLLTD Address
 |
||
APLLTD Latest News
APLLTD Business Profile
Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (API) and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, anti-diabetic, gynecology, acute, gastroenterology, ophthalmology, dermatology, nephrology/urology, orthopedics, cancer, inflammation, autoimmune diseases, anti-infective, cold and cough, and metabolic disorders, as well as hospital care and animal health. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India. Address: Alembic Road, Vadodara, India, 390003
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service